0 (0%) | 04-27 16:32 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 22.44 | 1-year : | 23.09 |
Resists | First : | 19.21 | Second : | 19.77 |
Pivot price | 18.99 | |||
Supports | First : | 18.32 | Second : | 15.25 |
MAs | MA(5) : | 18.85 | MA(20) : | 19.14 |
MA(100) : | 18.81 | MA(250) : | 18.29 | |
MACD | MACD : | -0.2 | Signal : | -0.1 |
%K %D | K(14,3) : | 39.3 | D(3) : | 36.2 |
RSI | RSI(14): 46.7 | |||
52-week | High : | 19.77 | Low : | 15.44 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PDI ] has closed above bottom band by 47.6%. Bollinger Bands are 79.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 19 - 19.06 | 19.06 - 19.12 |
Low: | 18.73 - 18.8 | 18.8 - 18.87 |
Close: | 18.84 - 18.94 | 18.94 - 19.06 |
Tue, 23 Apr 2024
Top Analyst Upgrades and Downgrades (APD, BERY, CL, CXS, DOW, FFIV, FMS, IMGN, LF, MCP, NS, OMC, PDLI ... - Yahoo Movies Canada
Sun, 21 Apr 2024
PDL BioPharma Beats on Q4 Earnings, Revenues Up Y/Y - Yahoo Movies UK
Thu, 22 Jun 2023
Dr. Charles Faint - Modern War Institute - United States Military Academy West Point
Mon, 12 Jul 2021
Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it ... - Nature.com
Tue, 08 Dec 2020
PDL Announces Timeline for Voluntarily Delisting from Nasdaq - PR Newswire
Fri, 02 Oct 2020
PDL BioPharma Completes Spin-Off of LENSAR - PR Newswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 286 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 15.4 (%) |
Shares Short | 210 (K) |
Shares Short P.Month | 360 (K) |
EPS | 0.67 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 28.29 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |